Aziyo Biologics Inc. logo

Aziyo Biologics (AZYO) stock

AZYO · Aziyo Biologics Inc. · NASDAQ

Website

What is the latest news on AZYO stock?

13D/Gago
SEC Form SC 13G filed by Aziyo Biologics Inc.

SC 13G - ELUTIA INC. (0001708527) (Subject)

All AZYO news

When does Aziyo Biologics report earnings?

Aziyo Biologics last reported on Aug 14, 2023, the date it announced on Jul 31, 2023. Before that it reported on May 10, 2023 and Mar 22, 2023.

AZYO earnings history

Latest news

25 items

Aziyo Biologics Inc. (AZYO) is a Medical Specialities company listed on NASDAQ. There were no new wire items for AZYO in the last 30 days. The most recent was published Feb 14, 2024.

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. The company also provides FiberCel, ViBone, and OsterGro V that are designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

AZYO FAQ

7 questions
  • What does Aziyo Biologics Inc. do?
    Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and...
  • Where does AZYO stock trade?
    Aziyo Biologics Inc. (AZYO) is listed on NASDAQ.
  • What sector and industry is AZYO in?
    Aziyo Biologics Inc. operates in the Health Care sector, Medical Specialities industry.
  • When did Aziyo Biologics Inc. go public?
    Aziyo Biologics Inc. (AZYO) completed its IPO in 2020.
  • What are analysts saying about AZYO?
    Aziyo Biologics Inc. has had 1 recent analyst action on file. The most recent action was from Cowen & Co.: Outperform with a $13.00 price target on 2022-03-04. Recent price targets cluster around $13.00.
  • What companies are similar to AZYO?
    Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), HUM (Humana Inc.), ILMN (Illumina Inc.), CI (The Cigna Group), LH (Labcorp Holdings Inc.). Compare AZYO side-by-side with any of them on Quantisnow.
  • How can I track AZYO on Quantisnow?
    Quantisnow aggregates Aziyo Biologics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AZYO to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change